Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Early Systemic Sclerosis by Bosentan

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Early systemic sclerosis~Exclusion Criteria:~* Age \> 70 or \< 18~* Pregnancy~* Nursing~* HIV~* Hb \< 8.5 g/l~* Systolic blood pressure \< 85 mmHg~* Lack of compliance~* Liver disease~* Hypersensitivity to bosentan~* Concurrent us of glibenclamide, ciclosporine A or tacrolimus -

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).